2-bromopalmitate has been researched along with Cardiomegaly in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahllöf, B; Edgley, AJ; Lanne, B; Ljung, B; Oakes, ND; Thalén, PG | 1 |
| Faccini, JM; Greaves, P; Higgins, AJ | 1 |
2 other study(ies) available for 2-bromopalmitate and Cardiomegaly
| Article | Year |
|---|---|
PPARgamma agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar rats.
Topics: Animals; Blood Proteins; Body Weight; Carbon Radioisotopes; Cardiomegaly; Deoxyglucose; Dietary Fats; Dietary Supplements; Epoxy Compounds; Fatty Acids; Fatty Acids, Nonesterified; Glucose; Heart Ventricles; Insulin; Male; Palmitates; PPAR gamma; Propionates; Proteins; Rats; Rats, Wistar; Time Factors; Triglycerides; Tritium | 2006 |
Coronary hyperemia and cardiac hypertrophy following inhibition of fatty acid oxidation. Evidence of a regulatory role for cytosolic phosphorylation potential.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cardiomegaly; Coronary Circulation; Creatine; Cytosol; Dogs; Fatty Acids; Glycine; Hemodynamics; Isoproterenol; Organ Size; Oxidation-Reduction; Oxygen Consumption; Palmitates; Phosphocreatine; Phosphorylation | 1985 |